Evidence map›Paper›PMID 41586317›Full record

ArticleFrontiers in cellular and infection microbiology2025

Early diagnosis and prognostic prediction of secondary bloodstream infections caused by

Hengxin Chen, Wenjia Gan, Xianling Zhou, Pingjuan Liu, Tangdan Ding, Hongxu Xu, Peisong Chen, Yili Chen

Abstract readMulticenter Study
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Carbapenem-resistantFrontiers in medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hengxin Chen *Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Wenjia Gan *Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Xianling ZhouDepartment of Clinical Immunology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Pingjuan LiuDepartment of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Tangdan DingDepartment of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Hongxu XuDepartment of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Peisong ChenDepartment of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Yili ChenDepartment of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Secondary bloodstream infections (sBSI) caused by Methods: The multicenter, retrospective study enrolled 4,267 ICU patients with Results: The AB-sBSI risk diagnosis model, constructed with 11 features, identified red cell distribution width as the most significant predictor. The AdaBoost model outperformed both comparative models (Linear Discriminant Analysis, Logistic Regression, LinearSVC) and the conventional biomarker C-reactive protein (AUC = 0.66), with AUCs of 0.937 in training and 0.786 in validation. For 30-day mortality prediction, another model based on 11 features selected lymphocyte count as the most influential variable. The AdaBoost model showed prominent efficacy, surpassing other model (Multilayer Perceptron, BernoulliNB, SGD) and achieving AUC values of 0.986 in training and 0.821 in validation. Conclusion: We developed two ML based models for predicting AB-sBSI risk and 30-day mortality. As a preliminary exploration, both models have been converted into accessible web tools. These tools are designed to assist clinicians in making informed decisions and promptly adjusting treatment strategies for critically ill patients.

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsBacteremiaMachine LearningAgedClassification AlgorithmsCritical IllnessEarly DiagnosisFemaleHumansIntensive Care UnitsMaleMiddle AgedPrediction AlgorithmsPredictive Learning ModelsPrognosisAcinetobacter baumanniidiagnosismachine learningprognosissecondary bloodstream infections

Identifiers

PMID41586317
PMCPMC12823858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.